Literature DB >> 26202400

The challenges of novel contrast agents for the imaging diagnosis of hepatocellular carcinoma.

Carmen Ayuso1, Jordi Bruix2.   

Abstract

Entities:  

Year:  2013        PMID： 26202400     DOI： 10.1007/s12072-013-9505-5

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  20 in total

1.  Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI.

Authors:  Jordi Rimola; Alejandro Forner; Silvia Tremosini; Maria Reig; Ramón Vilana; Luis Bianchi; Carlos Rodríguez-Lope; Manel Solé; Carmen Ayuso; Jordi Bruix
Journal:  J Hepatol       Date:  2012-02-04       Impact factor: 25.083

2.  Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis.

Authors:  Rita Golfieri; Matteo Renzulli; Vincenzo Lucidi; Beniamino Corcioni; Franco Trevisani; Luigi Bolondi
Journal:  Eur Radiol       Date:  2011-02-05       Impact factor: 5.315

3.  Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis?

Authors:  Mustafa R Bashir; Rajan T Gupta; Matthew S Davenport; Brian C Allen; Tracy A Jaffe; Lisa M Ho; Daniel T Boll; Elmar M Merkle
Journal:  J Magn Reson Imaging       Date:  2012-09-25       Impact factor: 4.813

Review 4.  Imaging of HCC.

Authors:  Carmen Ayuso; Jordi Rimola; Angeles García-Criado
Journal:  Abdom Imaging       Date:  2012-04

5.  Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

Authors:  Bernd B Frericks; Christoph Loddenkemper; Alexander Huppertz; Steffi Valdeig; Andrea Stroux; Marion Seja; Karl-Jürgen Wolf; Thomas Albrecht
Journal:  AJR Am J Roentgenol       Date:  2009-10       Impact factor: 3.959

6.  The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.

Authors:  Angelo Sangiovanni; Matteo A Manini; Massimo Iavarone; Raffaella Romeo; Laura V Forzenigo; Mirella Fraquelli; Sara Massironi; Cristina Della Corte; Guido Ronchi; Maria Grazia Rumi; Piero Biondetti; Massimo Colombo
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

7.  Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.

Authors:  G Schuhmann-Giampieri; H Schmitt-Willich; W R Press; C Negishi; H J Weinmann; U Speck
Journal:  Radiology       Date:  1992-04       Impact factor: 11.105

8.  Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.

Authors:  Jordi Rimola; Alejandro Forner; Maria Reig; Ramon Vilana; Carlos Rodríguez de Lope; Carmen Ayuso; Jordi Bruix
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

9.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.